DNA binding and topoisomerase II inhibitory activity of water-soluble ruthenium(II) and rhodium(III) complexes

被引:77
作者
Singh, Sanjay Kumar
Joshi, Shweta
Singh, Alok Ranjan
Saxena, Jitendra Kumar
Pandey, Daya Shankar [1 ]
机构
[1] Banaras Hindu Univ, Fac Sci, Dept Chem, Varanasi 221005, Uttar Pradesh, India
[2] Cent Drug Res Inst, Div Biochem, Lucknow 226001, Uttar Pradesh, India
关键词
D O I
10.1021/ic700885m
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
Water-soluble piano-stool arene ruthenium complexes based on 1-(4-cyanophenyl)imidazole (CPI) and 4-cyanopyridine (CNPy) with the formulas [(eta(6)-arene)RuCl2(L)] (L = CPl, eta(6)-arene = benzene (1), p-cymene (2), hexamethyl benzene (3); L = CNPy, eta(6)-arene = benzene (4), p-cymene (5), h examethylbenzene (6)) have been prepared by our earlier methods. The molecular structure of [(eta(6) -C6Me6)RuCl2(CNPy)] (6) has been determined crystallographically. Analogous rhodium(III) complex [(eta(5)-C5Me5)RhCl2(CPI)] (7) has also been prepared and characterized. DNA interaction with the arene ruthenium complexes and the rhodiurn complex has been examined by spectroscopic and gel mobility shift assay; condensation of DNA and B -> Z transition have also been described. Arene ruthenium(II) and EPh3 (E = P, As)-containing arene ruthenium(II) complexes exhibited strong binding behavior, however, rhodium(111) complexes were found to be Topo 11 inhibitors with an inhibition percentage of 70% (7) and 30% (7a). Furthermore, arene ruthenium complexes containing polypyridyl ligands also act as mild Topo 11 inhibitors (10%, 3c and 40%, 3d) in contrast to their precursor complexes. Complexes 4-6 also show significant inhibition of beta-hematin/hemozoin formation activity.
引用
收藏
页码:10869 / 10876
页数:8
相关论文
共 79 条
  • [1] In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer
    Aird, RE
    Cummings, J
    Ritchie, AA
    Muir, M
    Morris, RE
    Chen, H
    Sadler, PJ
    Jodrell, DI
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (10) : 1652 - 1657
  • [2] [Ru(η6-p-cymene)Cl2(pta)] (pta=1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane):: a water soluble compound that exhibits pH dependent DNA binding providing selectivity for diseased cells
    Allardyce, CS
    Dyson, PJ
    Ellis, DJ
    Heath, SL
    [J]. CHEMICAL COMMUNICATIONS, 2001, (15) : 1396 - 1397
  • [3] Ruthenium(II) complexes of redox-related, modified dipyridophenazine ligands: Synthesis, characterization, and DNA interaction
    Ambroise, A
    Maiya, BG
    [J]. INORGANIC CHEMISTRY, 2000, 39 (19) : 4256 - 4263
  • [4] Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis
    Ang, Wee Han
    Daldini, Elisa
    Scolaro, Claudine
    Scopelliti, Rosario
    Juillerat-Jeannerat, Lucienne
    Dyson, Paul J.
    [J]. INORGANIC CHEMISTRY, 2006, 45 (22) : 9006 - 9013
  • [5] Classical and non-classical ruthenium-based anticancer drugs: Towards targeted chemotherapy
    Ang, Wee Han
    Dyson, Paul J.
    [J]. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2006, (20) : 4003 - 4018
  • [6] Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: Influence of the ligands on drug efficacies and uptake
    Ang, WH
    Pilet, S
    Scopelliti, R
    Bussy, F
    Juillerat-Jeanneret, L
    Dyson, PJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (25) : 8060 - 8069
  • [7] [Anonymous], 1999, TOP BIOL INORG CHEM
  • [8] THE INTERACTION OF SPERMINE AND PENTAMINES WITH DNA
    BASU, HS
    MARTON, LJ
    [J]. BIOCHEMICAL JOURNAL, 1987, 244 (01) : 243 - 246
  • [9] Effects of NAMI-A and some related ruthenium complexes on cell viability after short exposure of tumor cells
    Bergamo, A
    Zorzet, S
    Gava, B
    Sorc, A
    Alessio, E
    Iengo, E
    Sava, G
    [J]. ANTI-CANCER DRUGS, 2000, 11 (08) : 665 - 672
  • [10] Optically active transition metal complexes .107. Synthesis, properties, stereochemistry and crystal structures of diastereomeric benzene-ruthenium(II) complexes with a chiral salicylideneaminato ligand
    Brunner, H
    Oeschey, R
    Nuber, B
    [J]. JOURNAL OF THE CHEMICAL SOCIETY-DALTON TRANSACTIONS, 1996, (08): : 1499 - 1508